中华胃肠外科杂志最新文献

筛选
英文 中文
[Guidelines for the development of acute care surgery].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20241209-00401
{"title":"[Guidelines for the development of acute care surgery].","authors":"","doi":"10.3760/cma.j.cn441530-20241209-00401","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20241209-00401","url":null,"abstract":"<p><p>Acute Care Surgery (ACS) is an emerging discipline of general surgery that integrates trauma, emergency surgery, critical care medicine, and surgical rescue. It is a modern model for the diagnosis and treatment of patients with acute and critical abdominal conditions. Compared to the traditional model, ACS integrates the theories and techniques of trauma, critical care, and surgery. It consolidates surgical wards and intensive care units into a single department for operational management. The care of acute care patients is led by physicians who are qualified in both critical care medicine and surgery. This model improves efficiency and significantly reduces morbidity and mortality of patients. Both international and domestic hospitals have had multiple surgical rescue teams that have embarked on exploratory work in the development of ACS, accumulating a certain amount of experience. The Expert Working Group of Acute Care Surgery, Chinese Medical Doctor Association Division of Surgeons has formed a preliminary guideline for the development of the Department of Acute Care Surgery based on the current experience and accomplishment in China for the reference of hospitals at all levels.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"13-20"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prognostic factors and survival analysis in rectal cancer patients with poor response to neoadjuvant therapy].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20240323-00108
H B Li, Y Qian, K X Li, C Wang, Z Sun, X Y Sun, L Xu, G N Zhang, B Wu, G L Lin, J Y Lu, K Hu, Y Xiao
{"title":"[Prognostic factors and survival analysis in rectal cancer patients with poor response to neoadjuvant therapy].","authors":"H B Li, Y Qian, K X Li, C Wang, Z Sun, X Y Sun, L Xu, G N Zhang, B Wu, G L Lin, J Y Lu, K Hu, Y Xiao","doi":"10.3760/cma.j.cn441530-20240323-00108","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20240323-00108","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To compare the impact of different treatment strategies on the survival outcomes in rectal cancer patients with poor response to neoadjuvant therapy, and to explore the survival-related influencing factors. &lt;b&gt;Methods:&lt;/b&gt; A retrospective cohort study was conducted. Between January 2018 and November 2022, the clinical, pathological, and follow-up data of 106 rectal cancer patients who received neoadjuvant therapy and were evaluated as grade 4 or 5 based on the Magnetic Resonance Tumor Regression Grade (mrTRG) from the rectal cancer database at Peking Union Medical College Hospital were retrospectively collected. Based on the post-neoadjuvant therapy assessment, patients were classified into three groups: the chemotherapy-radiotherapy group (23 patients), the consolidation therapy group (18 patients), and the standard treatment group (65 patients). General condition, pathological findings, selection of neoadjuvant therapy, comorbidities, as well as 3-year expected DMFS and OS were observed in the three groups. &lt;b&gt;Results:&lt;/b&gt; All 106 patients were followed up, with a median follow-up time of 28 (21, 38) months. The overall 3-year DMFS rate was 60%, and the 3-year OS rate was 74%. The 3-year DMFS in the standard treatment and consolidation therapy groups were 74% and 72%, respectively; the 3-year OS were 84%, 81%, respectively. The Log-rank test showed that there was no significant difference in the 3-year expected DMFS and OS between the standard treatment group and the consolidation therapy group (both &lt;i&gt;P&lt;/i&gt;&gt;0.05), but both groups had better survival outcomes than the chemotherapy-radiotherapy group (10% and 39%, respectively; all &lt;i&gt;P&lt;/i&gt;&lt;0.001). Multivariate Cox regression analysis indicated that the chemotherapy-radiotherapy only regimen was an independent risk factor for DMFS (HR=12.425, 95% CI: 4.436-34.594, &lt;i&gt;P&lt;/i&gt;&lt;0.001), and the independent risk factors for OS were chemotherapy-radiotherapy only regimen (HR=8.991, 95%CI:2.220-36.403, &lt;i&gt;P&lt;/i&gt;=0.002) and age≥65 years (HR=3.495, 95%CI: 1.017-12.009, &lt;i&gt;P&lt;/i&gt;=0.047). Stratified analysis showed that chemotherapy-radiotherapy only regimen was the independent risk factors for DMFS and OS in patients with extramural vascular invasion (EMVI) positive (&lt;i&gt;n&lt;/i&gt;=66) and mesorectal fascial invasion (MRF) positive (n=56) (all &lt;i&gt;P&lt;/i&gt;&lt;0.05). Whether consolidation therapy was added to the standard neoadjuvant treatment regimen was not an independent factor affecting 3-year expected DMFS or OS in rectal cancer patients with poor response to neoadjuvant therapy. Further comparisons between the standard neoadjuvant treatment and consolidation therapy groups showed no statistically significant differences in spincter-preservation rate or postoperative complication rates (both &lt;i&gt;P&lt;/i&gt;&gt;0.05). However, the consolidation therapy group had a longer interval between the end of radiotherapy and surgery [80.1 (50.8, 109.4) days vs. 61.8 (48.8, 74.8) days, &lt;i&gt;P&lt;/i&gt;&lt;0.001], and a higher","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"48-57"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Artificial intelligence for lymph node metastasis prediction in gastric cancer: research progress].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20240510-00172
S C Yan, W Peng, M Cheng, W R Yang, Y Y Wu
{"title":"[Artificial intelligence for lymph node metastasis prediction in gastric cancer: research progress].","authors":"S C Yan, W Peng, M Cheng, W R Yang, Y Y Wu","doi":"10.3760/cma.j.cn441530-20240510-00172","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20240510-00172","url":null,"abstract":"<p><p>Gastric cancer is a common tumor in China, and lymph node metastasis (LNM) is an independent prognostic factor for it. Accurately determining the risk of LNM in gastric cancer can help to formulate the treatment plan and estimate its staging and prognosis preoperatively. Existing means for evaluating LNM in gastric cancer have shortcomings such as low accuracy and high subjectivity. In recent years, artificial intelligence (AI) has begun to be used in medical research and clinical fields, which is of great significance in the era of precise individualized medicine. Combined with multimodal data including clinical, imaging, pathomics and molecular information, AI can improve the accuracy of LNM diagnosis and assist clinical decision-making, which has made significant progress recently. The aim of this review is to provide an overview of the history and status of AI for LNM prediction in gastric cancer, and to discuss the challenges and development directions.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"95-102"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The opportunities and challenges brought by the age of we media].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20241227-00428
M H Zheng, X S Xu, X Zhao
{"title":"[The opportunities and challenges brought by the age of we media].","authors":"M H Zheng, X S Xu, X Zhao","doi":"10.3760/cma.j.cn441530-20241227-00428","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20241227-00428","url":null,"abstract":"<p><p>In recent years, surgical research has entered the digital era, and the dissemination of medical knowledge has also begun to confront the challenge posed by we media. When we media first emerged, most doctors in public hospitals, who focused on \"medicine, education, and research\", held a reserved attitude towards it. However, we media has demonstrated remarkable resilience and has continuously evolved to align with the trend of social development. Faced with the future development direction and the existing sore points, how surgeons comprehend and respond to the surging current of the times is a conundrum before us. In this article, the author has sorted out the rise and development of we media, the status of its application in the medical field, and the predicaments faced by medical we media, and has looked forward to its development to broaden the thinking of surgeons for more comprehensive innovation and development.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"36-40"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Economic evaluations of postoperative complications after colorectal cancer surgery].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20241011-00338
T X Wei, T F Gu, Z Q Wu, F Shan, Z Y Li, J F Ji
{"title":"[Economic evaluations of postoperative complications after colorectal cancer surgery].","authors":"T X Wei, T F Gu, Z Q Wu, F Shan, Z Y Li, J F Ji","doi":"10.3760/cma.j.cn441530-20241011-00338","DOIUrl":"10.3760/cma.j.cn441530-20241011-00338","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; This study aims to analyze the economic impact of postoperative complications after colorectal cancer surgery. &lt;b&gt;Methods:&lt;/b&gt; A retrospective cohort study was conducted. Patients with a preoperative pathological diagnosis of colorectal cancer who met surgical indications and underwent surgical treatment were included, while those with incomplete hospitalization cost data were excluded. From March 2017 to March 2022, three hundred and ninety-two colorectal cancer patients treated at Peking University Cancer Hospital and Institute Gastrointestinal Cancer Center I, were enrolled. Descriptive statistics were performed on the incidence of complications, hospitalization costs, and postoperative length of stay. A cohort was established based on the presence of postoperative complications (POC) and absence of postoperative complications (non-POC) to study economic differences. Propensity score matching analysis was employed to reduce potential confounding factors. &lt;b&gt;Results:&lt;/b&gt; Among 392 colorectal cancer patients, 90 (23.0%) developed POC (POC group), while 302 were in the non-POC group. Significant statistical differences were found between the two groups in terms of operation duration, extent of resection, and stoma creation (all &lt;i&gt;P&lt;/i&gt; &lt; 0.05); other baseline indicators showed no significant differences (all &lt;i&gt;P&lt;/i&gt;&gt;0.05). The median hospitalization cost for patients with postoperative anastomotic leakage was 115 973 yuan, an increase of 38 941 yuan (50.5%) over the non-POC group's 77 059 yuan; the median hospitalization cost for patients with mechanical obstruction was 111 477 yuan, an increase of 34 418 yuan (44.7%) over the non-POC group; and the median hospitalization cost for patients with wound infection was 95 860 yuan, an increase of 18 801 yuan (24.4%) over the non-POC group. The median postoperative length of stay for patients with anastomotic leakage, mechanical obstruction, and wound infection was 22.0 days, 22.0 days, and 18.5 days, respectively, compared to 9.0 days in the non-POC group, extending by 13.0 days, 13.0 days, and 9.5 days. After propensity score matching, each group had 68 patients, and there were no statistically significant differences in preoperative and intraoperative observations between the two groups (all &lt;i&gt;P&lt;/i&gt;&gt;0.05); compared to the non-POC group, the hospitali- zation costs in the POC group significantly increased (89 165 yuan vs. 75 437 yuan, &lt;i&gt;P&lt;/i&gt;&lt;0.001), and the postoperative length of stay also significantly extended (14.0 days vs. 8.0 days, &lt;i&gt;P&lt;/i&gt;&lt;0.001). &lt;b&gt;Conclusions:&lt;/b&gt; The occurrence of POC after colorectal cancer surgery significantly increases hospitalization costs and length of stay. This study provides specific and accurate reference data for subsequent health economic decision-making. This is the first detailed economic impact analysis of postoperative complications of colorectal cancer with a large sample size, which includes an economic impact analysis for eac","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"41-47"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A case report of plexiform angiomyxoid myofibroblastic tumor of the gastric body].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20240328-00115
W J Liu, H L Wang, Y Wang
{"title":"[A case report of plexiform angiomyxoid myofibroblastic tumor of the gastric body].","authors":"W J Liu, H L Wang, Y Wang","doi":"10.3760/cma.j.cn441530-20240328-00115","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20240328-00115","url":null,"abstract":"","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"86-88"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Critical issues in surgical treatment for colorectal cancer].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20250106-00010
P Lan, X S He, Z J Zhang, B Zhang
{"title":"[Critical issues in surgical treatment for colorectal cancer].","authors":"P Lan, X S He, Z J Zhang, B Zhang","doi":"10.3760/cma.j.cn441530-20250106-00010","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20250106-00010","url":null,"abstract":"<p><p>Clinical research on colorectal cancer in China has developed rapidly in recent years. Based on evidence-based medicine, the Chinese Colorectal Cancer Diagnosis and Treatment Standards and the CSCO Guidelines for Colorectal Cancer are continuously updated, which have been instrumental in optimizing the full-process management of colorectal cancer and improving cancer outcomes. While significant progress has been made, we must remain aware that there are still many urgent and key issues to be solved in the field of surgical treatment e.g. sphincter-preserving strategies, surgical approaches, management of T1 stage tumors, and surgical treatment for metastatic colorectal cancer. In the future, more high-quality, original research from China will be needed to address these challenges, standardize surgical approaches, and improve treatment effect.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"21-27"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Impact of perineural invasion upon chemotherapy duration and survival benefit in stageⅢ colon cancer].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20240508-00170
J X Chen, W L Zhang, W F Wang, J B Li, X J Wu, Z H Lu, D B Xu, J Z Lin, J H Peng
{"title":"[Impact of perineural invasion upon chemotherapy duration and survival benefit in stageⅢ colon cancer].","authors":"J X Chen, W L Zhang, W F Wang, J B Li, X J Wu, Z H Lu, D B Xu, J Z Lin, J H Peng","doi":"10.3760/cma.j.cn441530-20240508-00170","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20240508-00170","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To investigate the prognostic impact of perineural invasion in patients with stageⅢ colon cancer and to clarify its guidance value for the duration of postoperative adjuvant chemotherapy. &lt;b&gt;Methods:&lt;/b&gt; This study employed a retrospective cohort study method. It analyzed 426 patients with stageⅢ colon cancer who underwent radical surgery at Sun Yat-sen University Cancer Center and Longyan First Affiliated Hospital of Fujian Medical University, between April 2008 and June 2020. Inclusion criteria: patients received at least 3 months of adjuvant CapeOX therapy post-surgery, had complete pathological data, and were followed up for at least 12 months after the last chemotherapy. Among these patients, 231 were male, the median age was 59 (50~67) years, and 263 tumors were located in the right-sided colon. Postoperative pathology indicated that 107 cases (25.12%) had neural invasion, and 131 patients (30.75%) had vascular tumor thrombus. All patients received at least 4 cycles of postoperative CapeOX adjuvant chemotherapy, with 193 patients receiving 8 cycles and 233 patients receiving 4 to 7 cycles of adjuvant chemotherapy. The study analyzed the impact of neural invasion status and the duration of adjuvant chemotherapy on disease-free survival (DFS). Furthermore, within subgroups stratified by different risk levels (referencing the criteria proposed by the IDEA study: high risk: T4, N2 or T4N2; low risk: T3N1) and different neural invasion statuses, the impact of the duration of adjuvant chemotherapy on prognosis was analyzed. &lt;b&gt;Results:&lt;/b&gt; The median follow-up time for the entire cohort was 94.00 months (55.27-128.80 months). Multivariate Cox analysis indicated that pathological T stage T4 (HR = 2.457, 95%CI: 1.499-4.029, &lt;i&gt;P&lt;/i&gt;&lt;0.001) and postoperative pathological confirmation of perineural invasion (HR = 2.465, 95% CI: 1.519-4.000, &lt;i&gt;P&lt;/i&gt;&lt;0.001) were independent adverse prognostic factors for 5-year DFS. In the perineural invasion-positive group, the 5-year DFS for patients who received 8 cycles of postoperative adjuvant CapeOX chemotherapy was 86.90%, compared to 58.22% for those who received 4-7 cycles, with statistically significant differences (both &lt;i&gt;P&lt;/i&gt;&lt;0.05). In the perineural invasion-negative group, the 5-year DFS for patients who received 8 cycles was 88.66%, compared to 90.99% for those who received 4-7 cycles, with no statistically significant differences (&lt;i&gt;P&lt;/i&gt;=0.929). Among IDEA high-risk patients with perineural invasion, the 5-year DFS was 91.81% for those who received 8 cycles versus 50.66% for those who received 4-7 cycles, showing a statistically significant difference (&lt;i&gt;P&lt;/i&gt;=0.003). In IDEA high-risk patients without perineural invasion, the 5-year DFS for those who received 8 cycles was 82.28% compared to 87.32% for those who received 4-7 cycles, with no statistically significant difference (&lt;i&gt;P&lt;/i&gt;=0.806). In the IDEA low-risk patients, no differences were observed in the 5-year DFS b","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"58-66"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pelvic floor reconstruction with gluteus maximus myocutaneous flap in the treatment of perineal wound healing failure after pelvic exenteration].
中华胃肠外科杂志 Pub Date : 2025-01-25 DOI: 10.3760/cma.j.cn441530-20231117-00176
Y Tao, Y L Wang, L Zhu, Z G Wang, N Su, J Zhang
{"title":"[Pelvic floor reconstruction with gluteus maximus myocutaneous flap in the treatment of perineal wound healing failure after pelvic exenteration].","authors":"Y Tao, Y L Wang, L Zhu, Z G Wang, N Su, J Zhang","doi":"10.3760/cma.j.cn441530-20231117-00176","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20231117-00176","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the value of pelvic floor reconstruction with gluteus maximus myocutaneous flap in second-stage surgery for patients with failed perineal wound healing after pelvic exenteration (PE). <b>Methods:</b> This was a descriptive case series study. The clinical data of 24 patients with locally advanced (LARC) or recurrent (LRRC) rectal cancer who underwent PE and had long-term nonunion of postoperative perineal wounds were collected from the department of colorectal surgery of the Second Affiliated Hospital of Navy Medical University (Shanghai Changzheng Hospital) from January 2022 to January 2023. The specific operation methods of pelvic reconstruction by gluteus maximus myocutaneous flap are as follows: the necrotic tissue of the perineal wound was debrided and rinsed repeatedly, the gluteus maximus muscle was cut and separated from the gluteus superior and inferior arteries, the middle muscle pedicle was retained, part of the skin and muscle were separated from the medial margin, part of the epidermis was removed, the muscle and subcutaneous tissue at the medial margin of the flap were fixed to the medial edge of the wound, negative pressure suction tubes were placed above and below the wound cavity and in the muscle space on the right side, and the subcutaneous muscle and fat layer were sutured. The skin was sutured intersegmentally, and a negative pressure suction device was placed on the wound surface. After surgery, the patient should remain prone, and the drainage tube should be placed for at least 7 days. The drainage tube can be removed after 24-hour drainage is less than 30 ml. Perineal wound healing and complications related to gluteal major myocutaneous flap were observed. <b>Result:</b> The median reconstruction time of 24 patients was 180 (150 ~ 230) minutes, and the median intraoperative blood loss was 100 (30 ~ 200) ml. 91.7% (22/24) patients had successful healing of perineal wound within 30 d after operation. After a follow-up of 6 months, no complete or partial flap necrosis occurred. The incidence of complications related to gluteus maximus myocutaneous flap was 8.3% (2/24). One patient had flap infection and sinus tract, and one patient had flap sinus tract. All patients healed after debridement under local anesthesia. <b>Conclusion:</b> For LARC/LRRC patients with poor perineal wound healing after PE, pelvic floor reconstruction with gluteus maximus myocutaneous flap in second-stage operation is safe and feasible, and could successfully close the perineal wound, and has a low incidence of postoperative flap-related complications.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"28 1","pages":"81-85"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress of colonic electrical stimulation in the treatment of chronic constipation]. 【结肠电刺激治疗慢性便秘研究进展】。
中华胃肠外科杂志 Pub Date : 2024-12-25 DOI: 10.3760/cma.j.cn441530-20240316-00102
M D Cai, Y Y Lu, J L Wang
{"title":"[Research progress of colonic electrical stimulation in the treatment of chronic constipation].","authors":"M D Cai, Y Y Lu, J L Wang","doi":"10.3760/cma.j.cn441530-20240316-00102","DOIUrl":"https://doi.org/10.3760/cma.j.cn441530-20240316-00102","url":null,"abstract":"<p><p>Chronic constipation refers to a reduction in the frequency of bowel movements and difficulty in defecation lasting for more than 6 months, with a comprehensive incidence rate of 15% in the population. Chronic constipation is a significant health concern that greatly affects the quality of life of patients and results in substantial healthcare resource consumption. Current common treatment strategies include lifestyle modifications, pharmacological therapy, biofeedback therapy, enemas, and surgical procedures, but the effectiveness of these approaches remains limited. Colonic electrical stimulation therapy is a newly proposed treatment strategy in recent years, which involves the application of external electrical current to correct abnormal physiological activities related to defecation. This article provides an overview of the mechanisms, efficacy, and factors influencing the use of colonic electrical stimulation in the treatment of chronic constipation, as well as a summary of the advantages of colonic electrical stimulation and possible challenges for future development.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"27 12","pages":"1293-1300"},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信